8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 25, 2004)

Filed October 25, 2004For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K report on October 25, 2004, to announce its financial results for the quarter and nine months ended September 30, 2004. This filing primarily serves to incorporate by reference a press release detailing these results. Investors should refer to Exhibit 99.1, the press release, for specific financial performance metrics, earnings per share, revenue figures, and any forward-looking statements or commentary provided by management regarding the company's performance and outlook. The report indicates that the company is providing updated financial information as of the specified reporting period. While the 8-K itself is brief, the attached press release is the critical document for understanding the company's operational and financial condition. Investors are encouraged to review this press release to assess the company's performance against expectations and to identify any significant trends or developments that may impact future performance.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on October 25, 2004.
  • 2The filing's primary purpose is to report financial results for the quarter and nine months ended September 30, 2004.
  • 3The detailed financial results are contained within an attached press release (Exhibit 99.1).
  • 4Investors should consult Exhibit 99.1 for specific performance data.
  • 5Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Quest Diagnostics' financial results for the third quarter and the first nine months of 2004. It incorporates a press release containing these details.

The specific financial results are detailed in the press release dated October 25, 2004, which is included as Exhibit 99.1 to this 8-K filing. You should refer to this exhibit for detailed figures on revenue, earnings, and other financial metrics.

The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.